R 944
Alternative Names: R-944Latest Information Update: 20 Aug 2008
At a glance
- Originator Roche
- Class
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 11 Jul 2008 Discontinued - Phase-I for HIV infections treatment in USA (unspecified route)
- 07 Aug 2006 No development reported - Phase-I for HIV infections treatment in USA (unspecified route)
- 30 Sep 2002 Phase-I clinical trials in HIV infections treatment in USA (unspecified route)